Fifth Third Bancorp Catalyst Pharmaceuticals, Inc. Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 650 shares of CPRX stock, worth $16,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650
Previous 438
48.4%
Holding current value
$16,484
Previous $9,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CPRX
# of Institutions
389Shares Held
99.3MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$474 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$215 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$140 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$86.8 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$79.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.61B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...